Phenotype of mice transplanted with unfractionated BM or FACS-purified LSK cells
. | Unfractionated BM . | LSK cells . | ||
---|---|---|---|---|
Control . | SCLtTA/BCR-ABL . | Control . | SCLtTA/BCR-ABL . | |
Total no. of transplanted cells per mouse | 1 × 106 | 1 × 106 | 1200 (+1 × 105 wt) | 1200 (+1 × 105 wt) |
No. of transplanted LSK cells per mouse | 230 | 398 | 1200 | 1200 |
WBCs, ×109/L | 5.2 ± 0.09 | 18.8 ± 9.9* | 4.82 ± 1.2 | 5.88 ± 1.9† |
Gr-1+CD11b+ cells in the PB, percentage | 20 ± 6.1 | 68.8 ± 14.52* | 28.5 ± 14.8 | 53.6 ± 16.1 |
Absolute no. of Gr-1+CD11b+ cells in the PB, ×103/μL | 0.9 ± 0.3 | 12.7 ± 7.4* | 1.5 ± 1.1 | 3.4 ± 2.1† |
Moribund appearance after BM transplantation, wk | Never | 8 | Never | 11 |
. | Unfractionated BM . | LSK cells . | ||
---|---|---|---|---|
Control . | SCLtTA/BCR-ABL . | Control . | SCLtTA/BCR-ABL . | |
Total no. of transplanted cells per mouse | 1 × 106 | 1 × 106 | 1200 (+1 × 105 wt) | 1200 (+1 × 105 wt) |
No. of transplanted LSK cells per mouse | 230 | 398 | 1200 | 1200 |
WBCs, ×109/L | 5.2 ± 0.09 | 18.8 ± 9.9* | 4.82 ± 1.2 | 5.88 ± 1.9† |
Gr-1+CD11b+ cells in the PB, percentage | 20 ± 6.1 | 68.8 ± 14.52* | 28.5 ± 14.8 | 53.6 ± 16.1 |
Absolute no. of Gr-1+CD11b+ cells in the PB, ×103/μL | 0.9 ± 0.3 | 12.7 ± 7.4* | 1.5 ± 1.1 | 3.4 ± 2.1† |
Moribund appearance after BM transplantation, wk | Never | 8 | Never | 11 |